Novartis MS drug cuts relapse rate by half compared to Sanofi medicine
The company plans to start asking health authorities for approvals by year’s end Novartis’s investigational multiple sclerosis…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Multiple Sclerosis
Novartis’s Sandoz licenses proposed multiple sclerosis biosimilar
The medicine is in Phase III clinical development for the treatment of relapsing-remitting multiple sclerosis (RRMS)
Space study seeks treatments for Parkinson’s, multiple sclerosis
Parkinson's disease and multiple sclerosis are neurodegenerative illnesses that damage the brain and central nervous system. The…
Multiple sclerosis treatment market value to reach $20 bn by 2024
The growth will primarily be driven by the continued uptake of premium products and an increase in treatment rates as a result of…
Merck plans registration of Cladribine tablets in Europe
Decision based on most recent data available from the Cladribine tablets clinical programme and newly performed analyses Merck…
Genzyme’s Lemtrada approved by the FDA
First approved in September 2013 in the European Union